currently endorsed production technology is not responsive enough to produce an effective vaccine in time for unexpected viral antigen shift. we need to cut th

currently endorsed production technology is not responsive enough to produce an effective vaccine in time for unexpected viral antigen shift. we need to cut the required lead time down to weeks, rather than months. we also need to stand up a surveilance network again.